BLTE

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Belite Bio Inc ADR

NASDAQ | BLTE

89.07

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 16, 2025)

$2.67B

Market Cap

-

P/E Ratio

-1.59

EPS

$90.00

52 Week High

$49.00

52 Week Low

HEALTHCARE

Sector

BLTE Chart

Recent Chart
Price Action

BLTE Technicals

Tags:

BLTE Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$449K
Total Revenue $0
Cost Of Revenue $449K
Costof Goods And Services Sold $449K
Operating Income -$40M
Selling General And Administrative $10M
Research And Development $30M
Operating Expenses $40M
Investment Income Net -
Net Interest Income $3.7M
Interest Income $3.7M
Interest Expense $20K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $449K
Income Before Tax -$36M
Income Tax Expense $6K
Interest And Debt Expense -
Net Income From Continuing Operations -$36M
Comprehensive Income Net Of Tax -
Ebit -$36M
Ebitda -$36M
Net Income -$36M

Revenue & Profitability

Earnings Performance

BLTE Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $152M
Total Current Assets $147M
Cash And Cash Equivalents At Carrying Value $32M
Cash And Short Term Investments $32M
Inventory -
Current Net Receivables $594K
Total Non Current Assets $5.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $4M
Intangible Assets Excluding Goodwill $4M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $113M
Other Current Assets $1.3M
Other Non Current Assets -
Total Liabilities $6.3M
Total Current Liabilities $6.1M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt $276K
Total Non Current Liabilities $261K
Capital Lease Obligations $537K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $537K
Other Current Liabilities $5.8M
Other Non Current Liabilities -
Total Shareholder Equity $146M
Treasury Stock -
Retained Earnings -$108M
Common Stock $3K
Common Stock Shares Outstanding $31M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$29M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $449K
Capital Expenditures $151K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$111M
Cashflow From Financing $84M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$36M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$449K
Total Revenue $0
Cost Of Revenue $449K
Costof Goods And Services Sold $449K
Operating Income -$40M
Selling General And Administrative $10M
Research And Development $30M
Operating Expenses $40M
Investment Income Net -
Net Interest Income $3.7M
Interest Income $3.7M
Interest Expense $20K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $449K
Income Before Tax -$36M
Income Tax Expense $6K
Interest And Debt Expense -
Net Income From Continuing Operations -$36M
Comprehensive Income Net Of Tax -
Ebit -$36M
Ebitda -$36M
Net Income -$36M

BLTE News

BLTE Profile

Belite Bio Inc ADR Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Belite Bio Inc ADR is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to the development of innovative therapies for age-related atrophic macular degeneration and autosomal recessive Stargardt disease. The company's commitment to addressing significant unmet medical needs in the ophthalmic domain is underscored by its efforts to advance proprietary drug candidates through rigorous clinical trials. By leveraging state-of-the-art research and a strategic focus on transformative therapies, Belite Bio is poised to become a pivotal player in the evolving landscape of ophthalmology, offering promising solutions that aim to enhance patient outcomes.

VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
YDKG
-49.73%
$0.09
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
F
-0.17%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
AADI
+24.28%
$2.61
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
FEMY
+35.37%
$0.74
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
AMD
-1.69%
$234.56
DFLI
-32.48%
$1.33
SOFI
+0.57%
$28.03
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
AAL
-4.88%
$11.89
CLF
-2.79%
$13.56
MARA
-11.27%
$20.26
GDXD
-10.23%
$0.60
LAES
-15.08%
$6.36
AMC
-2.30%
$2.75
BTBT
-9.11%
$3.69
RF
-5.61%
$23.35
GNPX
-43.39%
$0.47
QBTS
-9.64%
$40.46
BTG
+3.96%
$5.89
VSEE
-13.85%
$0.51
QS
-13.38%
$15.46
RR
-7.95%
$5.67
GPUS
-5.78%
$0.36
LGCB
+19.39%
$1.97
ABAT
-36.64%
$5.67
NAK
-4.34%
$2.64
HBAN
-5.18%
$15.37
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
RGTZ
+29.08%
$11.23
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
UUUU
-13.20%
$21.69
CLSK
-13.83%
$19.98
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
T
+0.49%
$26.20
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
SMR
-10.87%
$47.62
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
HIMS
-5.75%
$59.15
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
BAC
-4.03%
$50.17
JOBY
-8.69%
$16.07
SLNH
-2.33%
$4.19
IONQ
-9.41%
$65.59
TOVX
-48.34%
$0.43
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-5.05%
$51.08
VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
YDKG
-49.73%
$0.09
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
F
-0.17%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
AADI
+24.28%
$2.61
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
FEMY
+35.37%
$0.74
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
AMD
-1.69%
$234.56
DFLI
-32.48%
$1.33
SOFI
+0.57%
$28.03
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
AAL
-4.88%
$11.89
CLF
-2.79%
$13.56
MARA
-11.27%
$20.26
GDXD
-10.23%
$0.60
LAES
-15.08%
$6.36
AMC
-2.30%
$2.75
BTBT
-9.11%
$3.69
RF
-5.61%
$23.35
GNPX
-43.39%
$0.47
QBTS
-9.64%
$40.46
BTG
+3.96%
$5.89
VSEE
-13.85%
$0.51
QS
-13.38%
$15.46
RR
-7.95%
$5.67
GPUS
-5.78%
$0.36
LGCB
+19.39%
$1.97
ABAT
-36.64%
$5.67
NAK
-4.34%
$2.64
HBAN
-5.18%
$15.37
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
RGTZ
+29.08%
$11.23
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
UUUU
-13.20%
$21.69
CLSK
-13.83%
$19.98
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
T
+0.49%
$26.20
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
SMR
-10.87%
$47.62
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
HIMS
-5.75%
$59.15
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
BAC
-4.03%
$50.17
JOBY
-8.69%
$16.07
SLNH
-2.33%
$4.19
IONQ
-9.41%
$65.59
TOVX
-48.34%
$0.43
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-5.05%
$51.08
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.